Efficacy and safety of infliximab therapy in refractory upper respiratory tract sarcoidosis: experience from the STAT registry

Background: Upper respiratory tract (URT) involvement in sarcoidosis may be refractory to corticosteroids and immunosuppressants. Whether TNF-antagonists are efficient and safe in such phenotype is unknown. Methods: STAT is a French national drug registry including patients presenting sarcoidosis tr...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Sarcoidosis Vasc Diffuse Lung Dis
Main Authors: Barba, Thomas, Marquet, Alicia, Bouvry, Diane, Cohen-Aubart, Fleur, Ruivard, Marc, Debarbieux, Sébastien, Khouatra, Chahéra, Vighetto, Alain, de Parisot, Audrey, Valeyre, Dominique, Sève, Pascal
Formato: Artigo
Idioma:Inglês
Publicado em: Mattioli 1885 2017
Assuntos:
Original Article: Clinical Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7170073/
https://ncbi.nlm.nih.gov/pubmed/32476867
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.36141/svdld.v34i4.5817
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados